Martine Aliana Rothblatt is a lawyer and entrepreneur whose work explores the intersection of law, science, and ethics. Through her writings, she delves into profound questions about human existence and progress, drawing on her extensive knowledge in both legal and scientific fields. Her prose often examines the societal implications of technological advancement and the ethical challenges that accompany it. Rothblatt challenges readers to contemplate the future of humanity and our role within it.
The book presents a provocative argument for integrating Israel and Palestine into the United States, addressing potential objections with logical reasoning, historical examples, and current data. It emphasizes that this innovative approach could be crucial in alleviating the roots of terrorism within Middle Eastern politics, aiming to foster peace in a historically contentious region.
Martine Rothblatt has been at the forefront of AI research, and is a clearheaded thinker when it comes to understanding the ethical concerns that will play a role as we move towards living side by side with our mindclones. She gives us the philosophical and technological tools to understand the far-reaching implications of artificial intelligence.
This title was first published in 2003. Xenotransplantation - the transplantation of animal organs into humans - poses a fascinating moral dilemma. Should this ability to extend the lives of millions of older people be permitted given that it might trigger a new pandemic similar to AIDS? This study examines the moral dilemma from a combination of humanistic, legalistic, bioethical, economical and technological perspectives. The first part of the book demonstrates that xenografts are the only realistic near-term technological answer to the organ shortage problem. The balance of the book is devoted to assessing whether doctrines such as the 'right to health care' trump the moral and ethical conundrums posed by xenotransplantation. The book concludes with a 'geoethical' solution that proposes authorization of xenotransplantation subject to the prior implementation of a new international organization for epidemiology and basic health care. It also suggests that the costs of operating such an organization could be covered by a global tax on xenografts.
